Axona


About Axona

Axona is a prescription medical food intended for the clinical dietary management of the metabolic processes associated with mild to moderate Alzheimer’s disease.

Three decades of research have established that the brain of a person with Alzheimer’s disease has difficulty using its main source of energy: a sugar molecule called glucose.1 This lack of energy may correlate with memory problems and decrease a person’s ability to think, perceive, and reason (called cognition).2

Fortunately, these researchers have found an alternative source of energy for when the brain cannot use glucose properly: compounds called ketone bodies.1,3 This is where Axona may help. Axona is a unique   non-drug prescription therapy that supplies ketone bodies to the brain to help enhance memory and cognition.*4,5

A simple once-a-day medical food for people with Alzheimer’s disease, Axona can be easily mixed into a drink or soft food. It may be taken alone or in combination with other Alzheimer’s disease therapies.6     

Watch how Axona is shaking up Alzheimer's therapy 

 

Axona helpline

We are here to help. Call or email us with any questions or visit our website.
Phone: 1-877-649-0004
Email: axonainfo@accerapharma.com
Website: www.about-axona.com

 

Understanding Alzheimer’s disease


 

The normal, healthy brain depends on circulating glucose for fueling most of its functions. In Alzheimer’s disease, glucose is poorly utilized by nerve cells, and brain function thereby is decreased.1 Learn more at www.about-axona.com/understanding. 

Getting started


 

It's important for your loved one to start Axona off right in order to experience all of its benefits. The Axona Patient Starter Kit makes it easy to get started and helps the body get used to Axona. Ask your doctor about Axona Patient Starter Kits. Download the Patient Info Sheet below for more information for your doctor.

Memory screenings


 

Alzheimer's expert and board-certified neurologist Dr. Richard Isaacson discusses the importance of memory screenings. If you are age 65 or older or if you have a family history of Alzheimer's disease, schedule a screening today. If the test shows signs of memory loss or cognitive decline, you should discuss the results with your doctor. Visit www.nationalmemoryscreening.org to learn more. 

 

*Based on a randomized, double-blind, placebo-controlled, 90-day, phase IIb trial (therapeutic effect observed on ADAS–Cog scores in a preplanned secondary outcome [APOE4(-) subjects]).

 References: 1. Cunnane S, Nugent S, Roy M, et al. Brain fuel metabolism, aging, and Alzheimer's disease. Nutrition. 2011;27(1):3-20. 2. de Leon MJ, Ferris SH, George AE, et al. Positron  emission tomographic studies of aging and Alzheimer disease. AJNR Am J Neuroradiol. 1983;4(3):568-571. 3. Costantini LC, Barr LJ, Vogel JL, Henderson ST. Hypometabolism as a therapeutic  target in Alzheimer’s disease. BMC Neurosci. 2008;9(Suppl 2):S16. 4. Henderson ST, Vogel JL, Barr LJ, et al. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a  randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (Lond). 2009;6:31. 5. National Institute on Aging. Alzheimer's disease [fact sheet].  http://www.nia.nih.gov/sites/default/files/alzheimers_disease_fact_sheet_0.pdf. Reprinted September 2012. Accessed December 5, 2013. 6. Axona [prescribing information]. Broomfield, CO:  Accera, Inc.; November 2012.

 Axona is a prescription medical food intended for the clinical dietary management of the metabolic processes associated with mild to moderate Alzheimer’s disease.

 Axona should be used with caution in patients who are at risk for ketoacidosis, for example, patients with a history of alcohol abuse and poorly controlled diabetics; or those who have a history of  inflammation of the gastrointestinal system, metabolic syndrome, and/or renal dysfunction. Axona contains caseinate and whey (dairy), and lecithin (soy). Contains: milk and soy.

 Please see full prescribing information at www.about-axona.com.     

 Accera, Axona, and the Axona logo are trademarks or registered trademarks of Accera, Inc.
 Patents issued: USP 6,835,750, EP 1292294, JP 3486778, and USP 8,426,468; and patents pending.
 © 2013 Accera, Inc.  All rights reserved.  AC-13-695  12/13